Akebia Therapeutics (AKBA) EBIT Margin (QoQ) (2017 - 2026)
Akebia Therapeutics (AKBA) EBIT Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -411.00 |
| Mar 31, 2026 | 607.00 |
| Dec 31, 2025 | -2,241.00 |
| Sep 30, 2025 | -1,498.00 |
| Jun 30, 2025 | -102.00 |
| Mar 31, 2025 | 5,434.00 |
| Dec 31, 2024 | 264.00 |
| Sep 30, 2024 | -1,342.00 |
| Jun 30, 2024 | 2,582.00 |
| Mar 31, 2024 | -4,825.00 |
| Dec 31, 2023 | 3,345.00 |
| Sep 30, 2023 | -1,505.00 |
| Jun 30, 2023 | 4,803.00 |
| Mar 31, 2023 | -5,526.00 |
| Dec 31, 2022 | 9,474.00 |
| Sep 30, 2022 | -13,044.00 |
| Jun 30, 2022 | 7.84 Mn |
| Mar 31, 2022 | -7.84 Mn |
| Dec 31, 2021 | 15,554.00 |
| Sep 30, 2021 | 3,737.00 |